A 51-year-old with diabetes and obesity asks about weight‑loss medications to improve glycemia. Which statement aligns with U.S. guidance?...

Question

A 51-year-old with diabetes and obesity asks about weight‑loss medications to improve glycemia. Which statement aligns with U.S. guidance?

Accepted Answer

GLP‑1 receptor agonists provide substantial weight loss and A1C reduction and may be prioritized

Answer

Orlistat is preferred over GLP‑1 receptor agonists

Answer

No role for anti‑obesity medications in T2D

Answer

Phentermine is recommended long‑term first-line

Answer

Bariatric surgery should precede any pharmacotherapy

us-abim MCQ (SBA): Obesity & T2D-Pharmacotherapy